Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|December 9, 2025
Ianalumab plus Eltrombopag in Immune ThrombocytopeniaAdam Cuker, Thomas Stauch, Nichola Cooper, et al.
Blood|May 3, 2013
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemiaDavide Rossi, Valeria Spina, Riccardo Bomben, et al.
Blood|October 3, 2013
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive programMarco Ladetto, Chiara Lobetti-Bodoni, Barbara Mantoan, et al.
Blood|September 9, 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infectionLuca Arcaini, Caroline Besson, Marco Frigeni, et al.
American Journal of Hematology|March 5, 2019
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphomaFrancesco Maura, Luca Agnelli, Daniel Leongamornlert, et al.
Leukemia Research|December 10, 2013
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profileFrancesca R Mauro, Stefano Molica, Luca Laurenti, et al.
Hematological Oncology|May 2, 2020
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantationAndrés J M Ferreri, Marianna Sassone, Piera Angelillo, et al.
The Lancet. Oncology|July 3, 2017
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 studyAnnalisa Chiappella, Maurizio Martelli, Emanuele Angelucci, et al.
Leukemia|June 24, 2024
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemiaFederico Pozzo, Gabriela Forestieri, Filippo Vit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 StudyPier Luigi Zinzani, Alessandro Broccoli, Daniela Maria Gioia, et al.
Pageof 15